SLC27A1 and Miyoshi myopathy: RNA-sequencing revealed high expression of FATP1 in BM CD8+ T cells from MM patients, and FATP1 blockade rescued CD8+ T-cell function, thus representing a novel target for anti-MM immunotherapy.